Abstract
Antibiotic hypersensitivity reactions are relatively common in patients with cystic fibrosis (CF). The nature of the reactions and the mechanisms are no different in CF than the general population. Beta-lactam agents are the most common cause of these reactions. The risk depends on the specific betalactam agent used with Penicillins having a higher frequency of allergic reactions. There are several risk factors for developing these allergic responses, especially the increased usage. Since the available choices for antibiotic therapy is limited by the sensitivity of the organisms, management becomes a challenge. It is essential to classify the nature of the hypersensitivity reactions and determine the risks of repeat administration of the drug. Unfortunately, reliable skin tests are not available for all the antibiotics. RAST is of limited value. Recent data on cross-reactions between beta-lactam antibiotics and the option of newer agents offer useful alternative choices. Knowledge of the chemical structures of the antibiotics is useful for selecting suitable substitutes. Desensitization is a viable option in many of the reactions unless otherwise contradicted.
Similar content being viewed by others
References
Wills, R., Henry, R.L., and Francis, J.L. (1998), J. Paediatr. Child Health 34, 325–329.
Koch, C., Hjelt, K., Pedersen, S.S., Jensen, E.T., Jensen, T., Lanng, S., et al. (1991), Rev. Infect. Dis. 13(suppl 17), S608-S611.
Stead, R.J., Kennedy, H.G., Hobson, M.E., and Batten, J.C. (1985), Thorax 40, 184–186.
Pleasants, R.A., Walker, T.R., and Samuelson, W.M. (1994), Chest 106, 1124–1128.
Parker, C.W., Shapiro, J., Kern, M., and Eisen, H.N. (1962), J. Exp. Med. 115, 821–838.
Moss, R.B. (1989), J. Allergy Clin. Immunol. 83(6), 1138.
Sogn, D.D. (1986), J. Allergy Clin. Immunol. 78(suppl 5), 1051–1052.
Warner, J.O., Taylor, B.W., Norman, A.P., and Soothill, J.F. (1976), Arch. Dis. Child. 51, 507–511.
Pitcher-Wilmott, R.W., Levinsky, R.J., Gordon, I., Turner, M.W., and Matthew, D.J. (1982), Arch. Dis. Child. 57(8), 582–586.
McDonnel, T.J. and Fitzgerald, M.X. (1984), Lancet 1, 301–302.
Saxon, A., Adelman, D.C., Patel, A., Hajdu, R., and Calandra, G.B. (1988), J. Allerg. Clin. Immunol. 82, 213–217.
Erffmeyer, J.E. (1981), Ann. Allergy 47, 288–300.
Idsoe, O., Guthe, T., Willcox, R.R., and de Weck, A.L. (1994), Bull. WHO 38(2), 159–188.
Rourk, M. and Spock, A. (1970), CF Club Abstr., 20.
Agostini, M., Barlocco, G., Bonomi, U., Capelletti, L.J., Castellani, L., Conforti, M., et al. (1984), Drugs. Exp. Clin. Res. 8/9, 671–686.
Young, E.J., Fainstein, V., and Musher, D.M. (1982), Rev. Infect. Dis. 4, 69–77.
Ghosal, S. and Taylor, C.J. (1997), J. Antimicrob. Chemother. 39, 556–557.
Kishiyama, J.L. and Adelman, D.C. (1994), Drug Saf. 10, 318–327.
Girard, J.P. (1968), Int. Arch. Allergy 33, 428–438.
Saxon, A., Beall, G.N., Rohr, A.S., and Adelman, D.C. (1987), Ann. Intern. Med. 107, 204–215.
Adkinson Jr., N.F., Swabb, E.A., and Sugerman, A.A. (1984), Antimicrob. Agents Chemoth. 25, 93–97.
Adkinson Jr., N.F., Saxon, A., Spence, M.R., and Swabb, E.A. (1985), Rev. Infect. Dis. 7, S613–621.
Adkinson Jr., N.F. (1990), Am. J. Med. 88(suppl 3C), 12S-15S.
Vega, J.M. and Blanca, M. (1991), Allergy 46, 196–202.
Jensen, T., Pedersen, S.S., Nielsen, C.H., Hoiby, N., and Koch, C. (1987), J. Antimicrob. Chemother. 20, 585–594.
Moss, R.B., Babin, S., Blessing, J., and Lewiston, N.J. (1984), J. Pediatr. 104, 460–466.
Shepherd, G.M. (1992), Immunol. Allerg. Clin. North Am. 1, 611–633.
Audicana, M., Bernaola, G., Urrutia, I., et al., (1994), Allergy 49, 108–113.
Blanca, M., Perez, E., Garcia, J., et al. (1988), Allergy 43, 508–510.
Miranda, A., Blanca, M., Vega, J.M., Garcia, J., et al. (1996), J. Allerg. Clin. Immunol. 98, 671–677.
Sastre, J., Quijano, L.D., Novalbos, A., et al. (1996), Allergy 51, 383–386.
Novalbos, A., Sastre J., Cuesta J., De Las Heras M., Lluch-Bernal M., Bombin C., et al. (2001), Clin. Exp. Allergy 31, 438–443.
Anne, S. and Reisman, R.E. (1995), Ann. Allergy Asthma Immunol. 74, 161–170.
Blanca, M., Fernandez, M., Miranda, A., et al. (1989), J. Allergy Clin. Immunol. 83, 381–385.
Blanca, M., Vega, J.M., Garcia, J., et al. (1990), Clin. Exp. Allergy 20, 475–481.
Pimiento, A.P., Martinez, M.G., Mena, A.M., Gonzalez, A.T., De Paz Arranz, S., and Mosquera, M.R. (1998), Allergy 53, 624–625.
Dukes, M.N.G. (1992), 12th ed. Amsterdam: Excerpta Medica.
Samsoen, M., Metz, R., Melchior, E., and Fonssereau, J. (1980), Contact Dermatitis 6, 141.
Schorr, W.F. and Hegedus, S.I. (1973), Arch. Dermatol. 107, 533–539.
Forstrom, L. and Pirila, V. (1979), Acta Derm. Venerol. Suppl. (Stockh) 59, 67–69.
Schorr, W.F. and Ridgway, H.B. (1977), Contact Dermatitis 3, 133–137.
Earl, H.S. and Sullivan, T.J. (1987), J. Allergy Clin. Immunol. 79, 477–483.
Schretlen-Doherty, J. and Troutman, W.G. (1995), Ann. Pharmacother. 29, 704–706.
Burdge, D.R., Nakielna, E.M., and Rabin, H.R. (1995), Antimicrob. Agents Chemother. 39, 793.
Jensen, T., Pedersen, S.S., Hoiby, N., and Koch, C. (1991), Rev. Infect. Dis. 13(suppl 7), S594-S597.
Jaffe, A. and Bush, A. (1999), Pediat. Pulmonol. 28, 449–450.
Davis, H., McGoodwin, E., and Reed, T.G. (1989), Ann. Intern. Med. 111, 1041–1043.
Peters, B. and Pinching, A.J. (1989), Br. Med. J. 298, 605.
Wurtz, R.M., Abrams, D., Becker, S., et al. (1989), Lancet 1, 955–956.
Miller, M.S., Gaido, F., Rourk Jr., M.H., and Spock, A. (1990), Pediatr. Infect. Dis. J. 10(2), 164–165.
Deamer, R.L., Prichard, J.G., and Loman, G.J. (1992), Ann. Pharmacother. 26, 1081–1084.
Davila, I., Diez, M.L., Quirce, S., Fraj, J., De La Hoz, B., and Lazaro, M. (1993), Allergy 48, 388–390.
Lantner, R.R. (1995), J. Allergy Clin. Immunol. 96, 1001–1002.
Sullivan, T.J. (1982), J. Allergy Clin. Immunol. 69, 500–508.
Weiss, M.E. and Adkinson, N.F. (1988), Clin. Allergy 18, 515–540.
MacGlashan, Jr. D. and Lichtenstein, L.M. (1987), J. Immunol. 139, 501–505.
Sullivan, T.J. (1993), Current Views in Allergy & Immunology, Volume XXI. pp 204–301.
Naclerio, R.N., Mizrahi, E.A., and Adkinson, Jr., N.F. (1983), J. Allergy Clin. Immunol. 71, 294.
Sullivan, T.J. (1993), Allergy Principles and Practice, 4th ed., Mosby, St. Louis, MO.
Borish, L., Tamir, R., and Rosenwasser, L.J. (1987), J. Allergy Clin. Immunol. 80, 314–319.
Gorevic, P.D. and Levine, B.B. (1981), J. Allergy Clin. Immunol. 68, 267–272.
Moss, R.B. (1991), J. Allergy Clin. Immunol. 87, 78–88.
Gruchalla, R.S. (1998), Clin. Exp. Allergy 28 (4), 63–64.
Brown, L.A., Goldberg, N.B., and Shearer, W.T. (1982), J. Allergy Clin. Immunol. 69, 51–54.
Stark, B.J., Earl, H.S., Gross, G.N., Lumry, W.R., Goodman, E.L., and Sullivan, T.J. (1987), J. Allergy Clin. Immunol. 79, 523–532.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Ramesh, S. Antibiotic hypersensitivity in patients with CF. Clinic Rev Allerg Immunol 23, 123–142 (2002). https://doi.org/10.1385/CRIAI:23:1:123
Issue Date:
DOI: https://doi.org/10.1385/CRIAI:23:1:123